Optime Care, a nationally recognized pharmacy, specialty distributor and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, is pleased to announce that the first several episodes of “Rare Voices” Podcast Series Season Two are now available here. Hosted by Donovan Quill, president and CEO, Optime Care, the podcast uncovers insights from patient advocates, pharmaceutical innovators, insurance leaders, physicians and caregivers who share their experience and insights about the rare and orphan patient experience.
“We’re very excited about Season Two and our roster of high-profile industry experts who provoke, motivate and inspire interest among those who are interested in improving the patient experience for people with rare diseases,” says Quill. “We’re also very proud of Season One, which delivered a wealth of unique perspectives, eye-opening insights and an exploration of such questions as: Where do we go from here as we transition into a post-pandemic world? What are the next challenges in the rare and orphan disease space?”
The theme of Season Two of “Rare Voices” is “Onward” and features:
- Steve and Beth Aselage, father/daughter biopharma experts
- Jessica Ballinger, rare disease caretaker and influencer
- Dr. Jeffrey Miskoff, pulmonologist and critical care physician
- Dr. Jennifer Mulle, rare disease researcher
- Sanath Kumar Ramesh, OpenTreatments CEO, and rare disease dad
- Effie Parks, podcast host, Once Upon a Gene, mother to a rare disease warrior
- Doug Lindsay, rare disease pioneer and personal medical consultant
“This podcast is just one way that Optime demonstrates its commitment to providing exceptional support to caregivers, healthcare providers and biopharma partners,” says Quill.
Right now, the show is in search of compelling guests for its third season. If you know of someone with powerful insight into the lives of people with rare conditions, please submit them for consideration as a guest on the show.
About Optime Care
Optime Care, Inc. is a nationally recognized pharmacy, distribution and patient management organization offering a suite of comprehensive services tailored to maximize the therapeutic opportunities for the treatment of orphan and rare disorders. Our management team has previously partnered in the launch and management of more than 40 orphan products and programs and consistently implemented the best brand programs for the community. Our experience with small patient populations makes us uniquely qualified to help every stakeholder group impacted by these disorders. Optime Care has dual accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers. https://www.optimecare.com/